| Literature DB >> 30074147 |
Chang Liu1, Bin Luo2,3, Xiao-Xun Xie2,3, Xing-Sheng Liao1, Jun Fu2, Ying-Ying Ge2,3, Xi-Sheng Li1, Gao-Shui Guo1, Ning Shen4, Shao-Wen Xiao5, Qing-Mei Zhang6,7.
Abstract
Cancer testis antigens (CTAs) are attractive targets for tumor immunotherapy because of their tumor-specific expression. Since more than half of confirmed CTAs are located on the X-chromosome, we asked whether there is a link between CTA expression and X-chromosomes. Recent reports have shown that reactivation of the inactive X-chromosome, known as X-chromosome reactivation (XCR), a unique phenomenon that exists in many high-risk tumors in women, can transform the expression of many X-linked genes from monoallelic to biallelic. In this review, we discuss the link between CTA and XCR with the hopes of providing some novel insights into tumor biology.Entities:
Keywords: X-chromosome reactivation; cancer testis antigen; tumor immunotherapy
Mesh:
Substances:
Year: 2018 PMID: 30074147 DOI: 10.1007/s11596-018-1842-0
Source DB: PubMed Journal: Curr Med Sci ISSN: 2523-899X